Has fallen a long way decent revenues but they need to focus on margins which is probably why they are NOW tying to tighten up costs
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025